Litcius/Paper detail

Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study

Pushpa Narayanaswami, Donald B. Sanders, Laine Thomas, Dylan Thibault, Jason R. Blevins, Rishi Desai, Andrew Krueger, Kathie Bibeau, Bo Liu, Jeffrey T. Guptill, Vern C. Juel, Karissa Gable, Lisa D. Hobson‐Webb, Janice M. Massey, Shruti M. Raja, C. Douglas Emmet, Yuebing Li, David Polston, Steven J. Shook, Debbie Hastings, Zaeem A. Siddiqi, Muhammed Abid Alvi, Haley Andonian, Michael Nicolle, Denise Hulley, Emma Ciafaloni, Patricia P. Smith, Shawn Bird, Volkan Granit, Michael Benatar, Anne-Laure Gringon, Kristin Johnson, Daniel G. Larriviere, Kristina A. Brown, Hilda Gutiérrez, Katherine Ruzhansky, Aparna Choudhury, Michael K. Hehir, Noah Kolb, Waqar Waheed, Avery B. St. Sauveur, Araya Puwanant, David Lacomis, Srikanth Muppidi, Neelam Goyal, David H. Weinberg, James F. Howard, Manisha Chopra, Rabia Malik, Gilles Hoffmann, Anthony A. Amato, Gil I. Wolfe, Kara Patrick

2024The Lancet Neurology53 citationsDOI

Topics & Concepts

MedicineAzathioprineMyasthenia gravisAdverse effectInternal medicineProspective cohort studyImmunosuppressionCohortPrednisoneDiseaseMyasthenia Gravis and ThymomaAdrenal Hormones and DisordersPeripheral Neuropathies and Disorders
Comparative effectiveness of azathioprine and mycophenolate mofetil for myasthenia gravis (PROMISE-MG): a prospective cohort study | Litcius